Cargando…
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Tumor cells escape the immune surveillance system of the host through a process called immune tolerance. Immunotherapy targets molecules that serve as checks and balances in the regulation of immune response. Indoleamine-2,3-dioxygenase (IDO) is an intracellular enzyme, which through the process of...
Autores principales: | Moon, Yong Wha, Hajjar, Joud, Hwu, Patrick, Naing, Aung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678703/ https://www.ncbi.nlm.nih.gov/pubmed/26674411 http://dx.doi.org/10.1186/s40425-015-0094-9 |
Ejemplares similares
-
Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
Nanoconjugates to enhance PDT-mediated cancer
immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
por: Yang, Xueyuan, et al.
Publicado: (2021) -
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer
por: Panda, Anshuman, et al.
Publicado: (2021) -
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023)